The purpose of this study is to understand e-cigarette use and interest in quitting by exploring e vaping behaviors among a cohort of AYA survivors (N=500). The investigators will also examine demographic, medical, and psychosocial factors associated with vaping behaviors. Primary Objectives: Phase 1. * Objective 1. Identify characteristics of adolescent and young adult childhood cancer survivors (AYA CCS) nicotine vaping behaviors (e.g., e-cigarette use, interest in quitting, and quit attempts) and associations with demographic (e.g., sex, race, socioeconomic status, LGBTQ+ identification), cancer-specific (e.g., diagnosis, treatment factors), and psychosocial and behavioral factors. * Objective 2. Develop strategies to improve implementation of an evidence-based, mHealth vaping cessation program within an AYA oncology clinic. * Objective 2a: Use qualitative interviews to explore patient preferences regarding program implementation (e.g., timing of assessment of vaping behavior, confidentiality, referral approach) and identify barriers to uptake. * Objective 2b: Interview and/or ask healthcare providers (e.g., practitioners, advanced practice providers, social workers practicing in AYA oncology settings) to complete open- ended questionnaires related to current processes (e.g., workflow), needs, and barriers for assessing e-cigarette use and vaping cessation referral processes. Evaluate healthcare providers' information needs, preferences, and tools needed for integrating e- cigarette assessment and cessation program referrals into current practice. Phase 2. * Objective 3. Develop and test vaping assessment and referral implementation processes (developed from Objectives 1 \& 2)., and uptake of an established mHealth vaping cessation program * Objective 3a: Using qualitative and quantitative measures, we will assess the reach (% of eligible AYA CCS that enrolled in mHealth program), adoption (% providers making referrals), strategy potential (provider/patient perceptions of referral process; appropriateness of program for patients), and maintenance (barriers/facilitators to implementation) of the program.
Age range
13 Years – 24 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
E-cigarette use
Timeframe: Baseline, 1-week post TIQ completion
E-cigarette frequency
Timeframe: Baseline; 1-week post TIQ program completion]
Motivation and contemplation to quit
Timeframe: Baseline; 1-week post TIQ program completion
Prior history of e-cigarette quitting
Timeframe: Phase 2, 4-weeks post implementation
Patient Preferences for E-Cigarette Use Assessment and Referral Processes
Timeframe: Baseline; 1-week post TIQ program completion]
Healthcare Provider Perspectives of Program Implementation Potential
Timeframe: Baseline; 1-week post TIQ program completion
E-cigarette expectancies
Timeframe: Baseline
Patient-Provider E-Cigarette Communication
Timeframe: Baseline
Prior history of e-cigarette
Timeframe: Baseline; 1-week post TIQ program completion
Patient Preferences for E-Cigarette Use Assessment and Referral Processes.
Timeframe: Baseline
Healthcare Provider Perceptions of Barriers to E-Cigarette Assessment and Referral Processes.
Timeframe: Baseline
Healthcare Provider Post-Intervention Interviews
Timeframe: Phase 2, 4-weeks post implementation
Healthcare Provider Perspectives of Program Implementation Potential
Timeframe: Phase 2, 4 weeks Post-Implementation
Healthcare Provider Attitudes, Beliefs, Knowledge, and Communication about E-cigarettes
Timeframe: Baseline
Patient-Provider E-Cigarette Communication
Timeframe: 1-week post TIQ program completion
Satisfaction Survey
Timeframe: 1-week post TIQ program completion